Navigation Links
Healthcare Reform Implementation Should Boost IVD Industry Slightly: Kalorama Information Report
Date:8/26/2013

New York, NY (PRWEB) August 26, 2013

On the whole, Patient Protection and Affordable Care Act is expected to benefit the IVD and clinical lab test industry slightly, according to Kalorama Information. Sales are expected to rise an extra 1.3% more per year, in the next five years, than would have otherwise been seen without the law, according to a recent report from the firm. This finding was made in a recently published Kalorama Information report, “The Impact of Healthcare Reform (PPACA) On the U.S. IVD Market”.

The healthcare market research says the most significant IVD and clinical lab sales drivers resulting from the PPACA will be an expansion in the number of insured U.S. persons, increased utilization of tests related to nosocomial infections, and new coverage of wellness and prevention programs. Kalorama also notes the bill contains market restraints as well, and warns many questions about implementation and future effects remain.    

“The reform taketh away from IVD but you could say it ‘giveth’ a little more,” said Bruce Carlson, Publisher of Kalorama Information. “Several key provisions of the PPACA, in combination with favorable population demographics, will stimulate IVD product sales. It’s an industry that lives or dies based on test procedure numbers and thus the growth in the number of persons with health care coverage is good news for IVD.”

The Patient Protection and Affordable Care Act (H.R. 3590) passed in 2010 is a complex legislation that affects virtually every aspect of healthcare and many of its provisions are beginning to take effect now. The overall objective of the PPACA is to expand access to health care coverage for most U.S. citizens and legal residents by requiring individuals to have coverage and employers to either provide coverage or pay a penalty that would support coverage from a pool of public funds.

The report examines the proposed positive developments for the IVD industry resulting from PPACA such as an expansion in the number of insured U.S. persons, increased utilization of tests related to nosocomial infections, product innovation resulting from value-based pricing, and new coverage of wellness and prevention programs. The report also examines legislation components that might present challenges, such as the medical device excise tax and changes to Medicare reimbursement. Despite the known provisions, there are some unknown factors with healthcare reform implementation, also detailed in the report.

“Many issues have not yet been fully addressed,” said Carlson. “These include the future of the medical device tax, Medicare payment rates reform, state expansion of Medicaid, and public confusion about the PPACA.”

The report, “The Impact of Healthcare Reform (PPACA) On the U.S. IVD Market”, details the specific provisions of healthcare reform legislation and describes the current status. The report contains sales estimates for the historic 2012 period of the IVD market and forecasts are provided through 2022. The report also presents overall procedure volumes for IVD and laboratory tests. The report than analyzes the impact of various PPACA provisions on the IVD market. The report can be found at: http://www.kaloramainformation.com/Impact-Healthcare-Reform-7728373/ .

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11048882.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
2. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
3. Healthcare researchers recognized at SingHealth Duke-NUS Scientific Congress 2012
4. Daily disinfection of isolation rooms reduces contamination of healthcare workers hands
5. Health inequalities could be reduced by more effective healthcare, says new study
6. Healthcare ethics consultants share lessons learned
7. Kessler Foundation stroke expert receives $145,000 grant from Healthcare Foundation of New Jersey
8. Social environmental factors affect rehospitalization risk in home healthcare patients
9. TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
10. CWRU dental and nursing students collaborate for one-stop healthcare
11. University Hospitals & Philips Healthcare to showcase imaging technology at Cleveland Medical Mart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: